You are on page 1of 1

Federal Register / Vol. 68, No.

83 / Wednesday, April 30, 2003 / Notices 23155

Dated: April 22, 2003. Development Award for Clinicians, Scientist DEPARTMENT OF HEALTH AND
LaVerne Y. Stringfield, Development Awards, and Research Scientist HUMAN SERVICES
Awards; 93.278, Drug Abuse National
Director, Office of Federal Advisory
Research Service Awards for Research National Institutes of Health
Committee Policy.
Training; 93.279, Drug Abuse Research
[FR Doc. 03–10595 Filed 4–29–03; 8:45 am] Programs, National Institutes of Health, HHS) National Institute of Arthritis and
BILLING CODE 4140–01–M
Dated: April 22, 2002. Musculoskeletal and Skin Diseases;
LaVerne Y. Stringfield, Notice of Closed Meeting
DEPARTMENT OF HEALTH AND Director, Office of Federal Advisory Pursuant to section 10(d) of the
HUMAN SERVICES Committee Policy. Federal Advisory Committee Act, as
[FR Doc. 03–10596 Filed 4–29–03; 8:45 am] amended (5 U.S.C. Appendix 2), notice
National Institutes of Health BILLING CODE 4140–01–M if hereby given of the following meeting.
The meeting will be closed to the
National Institute on Drug Abuse;
public in accordance with the
Notice of Closed Meetings DEPARTMENT OF HEALTH AND provisions set forth in sections
Pursuant to section 10(d) of the HUMAN SERVICES 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Federal Advisory Committee Act, as as amended. The grant applications and
National Institutes of Health
amended (5 U.S.C. Appendix 2), notice the discussions could disclose
is hereby given of the following National Institute of Mental Health; confidential trade secrets or commercial
meetings. Notice of Closed Meeting property such as patentable material,
The meetings will be closed in and personal information concerning
accordance with the provisions set forth Pursuant to section 10(d) of the individuals associated with the grant
in sections 552b(c)(4) and 552b(c)(6), Federal Advisory Committee Act, as applications, the disclosure of which
Title 5 U.S.C., as amended. The contract amended (5 U.S.C. Appendix 2), notice would constitute a clearly unwarranted
proposals and the discussions could is hereby given of the following invasion of personal privacy.
disclose confidential trade secrets or meeting.
Name of Committee: National Institute of
commercial property such as patentable The meeting will be closed to the
Arthritis and Musculoskeletal and Skin
material, and personal information public in accordance with the Diseases Special Emphasis Panel, Review of
concerning individuals associated with provisions set forth in sections Research Project Grants.
the contract proposals, the disclosure of 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Date: May 27, 2003.
which would constitute a clearly as amended. The contract proposals and Time: 8:30 a.m. to 5 p.m.
the discussions could disclose Agenda: To review and evaluate grant
unwarranted invasion of personal applications.
privacy. confidential trade secrets or commercial
property such as patentable material, Place: Double Tree Rockville, 1750
Name of Committee: National Institute on Rockville Pike, Rockville, MD 20852.
and personal information concerning
Drug Abuse Special Emphasis Panel, Contact Person: Aftab A. Ansari, PhD,
individuals associated with the contract Scientific Review Administrator, National
‘‘Develop and Maintain Substance Abuse
Prevention Methodological Software’’. proposals, the disclosure of which Institute of Arthritis and Musculoskeletal and
Date: May 1, 2003. would constitute a clearly unwarranted Skin Diseases, 6701 Democracy Plaza,
Time: 9:30 a.m. to 5 p.m. invasion of personal privacy. Bethesda, MD 20892, (301) 594–4952.
Agenda: To review and evaluate contract Name of Committee: National Institute of (Catalogue of Federal Domestic Assistance
proposals. Mental Health Special Emphasis Panel, Program Nos. 93.846, Arthritis,
Place: Residence Inn Bethesda, 7335 Contract Review: Flexible Decision Support Musculoskeletal and Skin Diseases Research,
Wisconsin Avenue, Bethesda, MD 20814. Systems. National Institutes of Health, HHS)
Contact Person: Lyle Furr, Contract Review Date: May 16, 2003.
Dated: April 24, 2003.
Specialist, Office of Extramural Affairs, Time: 9 a.m. to 1 p.m.
National Institute on Drug Abuse, National Agenda: To review and evaluate contract LaVerne Y. Stringfield,
Institute of Health, DHHS, 6001 Executive proposals. Director, Office of Federal Advisory
Boulevard, Room 3158, MSC 9547, Bethesda, Place: Holiday Inn Select Bethesda, 8120 Committee Policy.
MD 20892–9547, (301) 435–1439. Wisconsin Ave., Bethesda, MD 20814. [FR Doc. 03–10664 Filed 4–29–03; 8:45 am]
This notice is being published less than 15 Contact Person: Richard E. Weise, PhD,
BILLING CODE 4140–01–M
days prior to the meeting due to the timing Scientific Review Administrator, Division of
limitations imposed by the review and Extramural Activities, National Institute of
funding cycle. Mental Health, NIH, Neuroscience Center,
6001 Executive Boulevard, Room 6140, DEPARTMENT OF HEALTH AND
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel MSC9606, Bethesda, MD 20892–9606, 301– HUMAN SERVICES
‘‘Synthesis and Distribution of Drugs of 443–1225, rweise@mail.nih.gov.
Abuse and Related Compounds.’’ (Catalogue of Federal Domestic Assistance National Institutes of Health
Date: May 21, 2003. Program Nos. 93.242, Mental Health Research
Time: 9:30 a.m. to 5 p.m. Grants; 93.281, Scientist Development National Institute of Arthritis and
Agenda: To review and evaluate contract Award, Scientist Development Award for Musculoskeletal and Skin Diseases;
proposals. Clinicians, and Research Scientist Award; Notice of Closed Meeting
Place: Bethesda Marriott, 5151 Pooks Hill, 93.282, Mental Health National Research
Service Awards for Research Training, Pursuant to section 10(d) of the
Road Bethesda, MD 20814.
Contact Person: Eric Zatman, Contract National Institutes of Health, HHS) Federal Advisory Committee Act, as
Review Specialist, Office of Extramural amended (5 U.S.C. Appendix 2), notice
Dated: April 21, 2003. is hereby given of the following
Affairs, National Institute on Drug Abuse,
National Institute of Health, DHHS, 6001 Anna Snouffer, meeting.
Executive Boulevard, Room 3158, MSC 9547, Acting Director, Office of Federal Advisory The meeting will be closed to the
Bethesda, MD 20892–9547, (301) 435–1438. Committee Policy. public in accordance with the
(Catalogue of Federal Domestic Assistance [FR Doc. 03–10597 Filed 4–29–03; 8:45 am] provisions set forth in sections
Program Nos. 93.277, Drug Abuse Scientist BILLING CODE 4140–01–M 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

VerDate Jan<31>2003 13:22 Apr 29, 2003 Jkt 200001 PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 E:\FR\FM\30APN1.SGM 30APN1